Diabetes Mellitus Type 2 Perspective

 
 
  • Diabetes and Depression: Getting Active   An exploration of clinical research into physical activity and counseling as tools to control glucose.
  • SGLT2 Inhibitors: Is This the Start of a New Era? Gregory Nichols discusses exciting new clinical trial results demonstrating the benefits of SGLT2 inhibitors, as presented at the AHA 2018 Scientific Sessions.
  • Can Diet Reverse Type 2 Diabetes? Recent studies on the effect of low-carb diets on type 2 diabetes produce persuasive results, but experts debate about what constitutes an actual 'reversal.'
  • Top News From AHA 2018: Slideshow Highlights include new guidelines on cholesterol management and physical activity, plus potentially practicing changing results with high-dose omega-3 for CVD prevention.
  • Rapid Deterioration in Type 2 Diabetes: Rethink the Diagnosis   Differences in response to treatment and other characteristics help determine which of your type 2 patients actually have type 1 diabetes.
  • Eating in the Raw: Are Raw Food Devotees Right or at Risk? The centuries-old raw food movement is experiencing a resurgence. Is this diet ancient wisdom or modern folly?
  • For the Good of Your Patients, Use SGLT2 Inhibitors   Don't let mixed messages about SGLT2 inhibitors and reports of adverse effects deter you from prescribing these drugs, says Per-Henrik Groop.
  • Surviving the Holidays With Diabetes Celebrating the holidays doesn't have to be a choice between losing glycemic control or missing out on the fun. Dr Akshay Jain provides some tips to help guide discussions on safe holiday eating.
  • Rapid Weight Loss: Motivating Patients to Change Lifestyle   A 2-month rapid weight loss period puts patients in a frame of mind to avoid diabetes through lifestyle change.
  • Mediterranean Diet's Benefits May Extend to Multiple Diseases Dr William F. Balistreri on the latest evidence showing how we can eat our way toward improved health.
  • Put the Focus on Dinner for Blood Sugar Control   What do you do for patients in whom multiple combinations of oral antihyperglycemics are failing to control blood sugar levels? Dr Cyrus Desouza says to focus on the largest meal of the day.
  • Prevention of Type 2 Diabetes Highlighted at EASD 2018 Dietary changes and regular exercise are proven interventions that reduce the risk for type 2 diabetes, but with rates of obesity on the rise, other strategies may be required.
  • Plant-Based Diet to Lower Type 2 Diabetes Risk: Is It All or Nothing?   Vegan or vegetarian diets are difficult to sell to Western populations. Dr Trudy Voortman says that it doesn't have to be all or nothing--adding plant-based foods will lower type 2 diabetes risk.
  • Why Aren't We Prescribing Pills for Obesity? Dr Caroline Apovian says obesity is a chronic condition that may require pharmacotherapy or even bariatric surgery. So why aren't they included in the 2018 USPSTF recommendation statement?
  • Simple Tips to Explain Type 2 Diabetes Management   These analogies may help patients with type 2 diabetes understand some of the difficult challenges of long-term management.
  • Prediabetes: Forget Lifestyle and Just Prescribe Drugs?   New data suggest that an aggressive pharmacotherapy approach can stop progression to diabetes, but are patients--and clinicians--on board with it?
  • Sarcopenia in Liver Disease Patients with end-stage liver disease are at an increased risk of developing sarcopenia; however, early recognition and management prior to liver transplantation may improve post-transplant outcomes.
  • Top News From EASD 2018: Slideshow Large postmarketing drug efficacy and safety data plus new consensus guidelines on patient-centered management of type 2 diabetes featured prominently this year.
  • Oral Semaglutide a 'PIONEER' in the Treatment of T2D   Dr Martin Haluzik discusses the results of the PIONEER 1 trial, which evaluated the efficacy and safety of oral semaglutide, the first GLP-1 receptor agonist in tablet formulation.
  • 'WIN' With Women in Diabetes Research and Clinical Practice   Dr Darleen Sandoval discusses the Women's Interprofessional Network of the American Diabetes Association and the group's goals, aimed at supporting women in diabetes research and clinical practice.